Gene: ISOC1
Official Full Name: isochorismatase domain containing 1provided by HGNC
Gene Summary: Predicted to be located in peroxisome. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23192 | ISOC1 Knockout cell line (HeLa) | Human | ISOC1 | 1:3~1:6 | Negative | Online Inquiry |
KO23193 | ISOC1 Knockout cell line (HCT 116) | Human | ISOC1 | 1:2~1:4 | Negative | Online Inquiry |
KO23194 | ISOC1 Knockout cell line (HEK293) | Human | ISOC1 | 1:3~1:6 | Negative | Online Inquiry |
KO23195 | ISOC1 Knockout cell line (A549) | Human | ISOC1 | 1:3~1:4 | Negative | Online Inquiry |
ISOC1 Gene Knockout Cell Lines are advanced cellular models specifically engineered to provide insights into the biological functions of the ISOC1 gene, which is implicated in various cellular processes and disease mechanisms. These cell lines are obtained through targeted gene-editing technologies, such as CRISPR-Cas9, allowing for the precise inactivation of the ISOC1 gene. By creating knockout models, researchers can study the resulting phenotypic changes with high accuracy, enabling the exploration of the gene's role in metabolic pathways, cellular differentiation, and responses to environmental stimuli.
The primary mechanism through which ISOC1 Gene Knockout Cell Lines operate involves the disruption of the ISOC1 gene locus, which results in the loss of function of the encoded protein. This loss-of-function model is crucial for elucidating the gene’s biological significance and its contributions to various physiological and pathological states, including cancer and metabolic disorders. Researchers can employ these cell lines in assays to evaluate gene interactions, drug responses, and the mechanisms of disease progression, ultimately leading to the identification of potential therapeutic targets.
In terms of scientific importance, these cell lines serve as vital tools in both basic and applied research settings. They allow for rigorous investigation into gene function and interaction networks, and they are particularly valuable in pharmacogenomics and gene therapy development. The ISOC1 Gene Knockout Cell Lines are also pivotal for translational research, bridging the gap between fundamental discoveries and clinical applications.
Comparatively, these cell lines present unique advantages over other standard cell lines, such as the provision of a homogenous population lacking the specific ISOC1 gene, which enhances reproducibility in experimental outcomes. Furthermore, they are designed for ease of use and integration into existing workflows, making them a convenient choice for researchers and clinicians.
In summary, ISOC1 Gene Knockout Cell Lines represent a powerful resource for understanding gene function and exploring novel treatment strategies. They are backed by our company’s extensive expertise in cell line development and gene editing technologies, ensuring that our products meet the highest standards of quality and reliability. By choosing these knockout models, researchers embark on a pathway to discover transformative insights that could lead to breakthroughs in health and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.